GNOM (GNOM) Stock Price & Analysis
GNOM (GNOM) rose 2.11% to USD 48.9 as of June 10, 2026 at 10:40 UTC, according to Nexqual real-time market data.
GNOM last closed at USD 47.89; the session ranged USD 47.22–48.9 on volume of 9,130 shares. Market capitalization is —, with a 52-week range of USD 32.08–51.42 (NGM). Source: Nexqual, June 10, 2026 at 10:40 UTC.
Key Statistics (as of June 10, 2026 at 10:40 UTC)
| Price | USD 48.9 |
|---|---|
| Change | ▲ 2.11% (up) |
| Previous Close | USD 47.89 |
| Open | USD 48.36 |
| Day Range | USD 47.22 – 48.9 |
| 52-Week Range | USD 32.08 – 51.42 |
| Volume | 9,130 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (GNOM)
Nexqual's technical model rates GNOM "STRONG BUY" based on 5 bullish and 0 bearish signals across 123 daily candles, as of June 10, 2026 at 10:40 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 50.81 (neutral) |
| vs SMA50 | Above (USD 46.04) |
| MACD | 0.88 (positive) |
Financial Health Score (GNOM)
Nexqual rates GNOM's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 10:40 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| IDNA | iShares Genomics Immunology and | USD 29.2 | ▲ 0.21% |
| EBIZ | Global X E-commerce ETF | USD 27.38 | ▲ 0.44% |
| HEAL | Global X HealthTech ETF | USD 26 | ▲ 3.11% |
| SNSR | Global X Internet of Things ETF | USD 50.05 | ▲ 1.11% |
| FINX | Global X FinTech ETF | USD 23.81 | ▲ 0.67% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 10:40 UTC. This page is informational and not investment advice.